Drugs / 131I-chTNT-1/B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02724267 | Nov 2012 → Jun 2015 | hepatocellular carcinoma | Eastern Hepatobiliary Surgery Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 131I-chTNT-1/B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02724267 ↗ |
| Route | Intravenous | “intravenous administration” NCT02724267 ↗ |